Arcadia Consumer Healthcare, Inc., headquartered in the United States, is a prominent player in the consumer healthcare industry, specialising in over-the-counter (OTC) products. Founded in 2018, the company has quickly established itself as a trusted name, focusing on innovative solutions that enhance everyday health and wellness. With a diverse portfolio that includes pain relief, cold and allergy remedies, and digestive health products, Arcadia stands out for its commitment to quality and efficacy. The company’s unique approach combines scientific research with consumer insights, ensuring that its offerings meet the evolving needs of health-conscious individuals. Recognised for its rapid growth and market adaptability, Arcadia Consumer Healthcare continues to expand its operational reach across North America and beyond, solidifying its position as a leader in the competitive consumer healthcare landscape.
How does Arcadia Consumer Healthcare, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Arcadia Consumer Healthcare, Inc.'s score of 29 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Arcadia Consumer Healthcare, Inc. reported total carbon emissions of approximately 23,000 kg CO2e, comprising 8,000 kg CO2e from Scope 1 and 15,000 kg CO2e from Scope 2 emissions. The company has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 emissions to near zero by 2025. Additionally, Arcadia plans to achieve a 30% reduction in Scope 1 and Scope 2 emissions from a 2020 baseline by 2030. These initiatives reflect the company's proactive approach to addressing climate change and its commitment to sustainability within the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 8,000 |
| Scope 2 | 15,000 |
| Scope 3 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Arcadia Consumer Healthcare, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

